Improvised bubble continuous positive airway pressure (BCPAP) device at the National Hospital Abuja gives immediate improvement in respiratory rate and oxygenation in neonates with respiratory distress by Audu, LI et al.





Improvised bubble continuous  
positive airway pressure (BCPAP) 
device at the National Hospital 
Abuja gives immediate  
improvement in respiratory rate 
and oxygenation in neonates with  
respiratory distress  
Accepted: 15th August 2014 
 
Audu LI 
Otuneye AT, Mairami AB  
Mukhtar MY 
Department of Paediatrics,  
National Hospital Abuja, Nigeria. 
Email: drauduli@yahoo.com 
 
(      )
DOI:http://dx.doi.org/10.4314/njp.v42i1,4 
Abstract:  Background: Prematur-
ity accounts for 25% of Neonatal 
mortality in Nigeria and Respira-
tory Distress Syndrome is respon-
sible for half of these deaths.  
Introducing continuous positive 
airway pressure for the treatment 
of RDS in Nigeria where health 
care financing is predominantly 
out-of-pocket is quite challenging. 
It was hypothesized that applying 
the principle of under-water-seal 
pressure generation could convert 
a simple oxygen delivery system 
into an effective Bubble CPAP 
device. 
Objectives: To provide evidence 
in support of the immediate clini-
cal effectiveness of the NH-
BCPAP device. 
Design/Methods: At the neonatal 
unit of the National Hospital 
Abuja, we assembled a circuit of 
tubing connecting a gas source 
(oxygen concentrator or cylinder) 
through an interface (nasal 
prongs) to the baby and this was 
further connected through an ex-
piratory tube to an under-water-
seal bottle to generate CPAP. The 
device is activated by turning on 
the oxygen source. The device 
was applied to preterm babies with 
RDS as well as some term babies 
with respiratory distress admitted 
into the neonatal intensive care 
units. Respiratory rate, SPO2 and 
other signs of respiratory distress 
were monitored before and at 1 
hour, 6 hours and 12 hours after 
the application. 
Results: Forty eight newborn  
babies with respiratory distress 
were treated with the device out of 
whom twenty three (48%) were 
very low birth weight with respira-
tory distress syndrome. The mean 
respiratory rate dropped from 64.5
(19.2)/min before commencement 
of CPAP to 59.5(11.6)/min, 56.6
(10.5), and 56.6(10.7) at 1, 6 and 
12 hours respectively, p<0.05. The 
corresponding values for SPO2 
were 84.5(14) before and 95.9
(5.3), 95.9(6.5) and 96.9(6.4) at 1, 
6 and 12 hours respectively, 
p<0.05. The respiratory changes 
were however less marked among 
very low birth weight babies. 
Conclusion: The simplified cus-
tomized device produces clinical 
responses similar to those reported 




Prematurity accounts for 25% of neonatal mortality in 
Nigeria1 and respiratory distress syndrome (RDS) is 
responsible for half of these deaths2. Effective manage-
ment of respiratory distress syndrome is therefore a criti-
cal factor in their survival. Some form of respiratory 
support is required with or without surfactant replace-
ment.   Mechanical ventilation which was used as the 
main thrust of respiratory intervention over the years to 
salvage these babies is fraught with several complica-
tions including chronic lung disease of prematurity3. 
Continuous Positive Airway Pressure (CPAP) is increas-
ingly used in the management of preterm babies with
RDS, with a concomitant decrease in the use of  
mechanical ventilation in tertiary and non- tertiary 
health institutions4. Respiratory assistance with continu-
ous positive airway pressure (CPAP) is often sufficient 
to tide a preterm infant through RDS. Introducing CPAP 
in a low-resource setting is quite challenging and this
has limited its use to a few centers in Nigeria.  CPAP 
use may be associated with nasal septum erosion,  
interference with enteral intake (“CPAP belly”) and 
rarely, pneumothorax. Careful selection of appropriate 
size nasal prongs, passage of orogastric tube for inte -
mittent gastric decompression and careful attention o 
pressure delivered will minimize these challenges. 
 
Adaptation of Bubble –CPAP: Driven by the desire to 
provide effective and yet affordable treatment for RDS 
we resorted to the use of  locally sourced materials and 
applied the principle of ‘under-water seal’ pressure gen-
eration in BCPAP and arrived at a modification of the
existing bubble CPAP device which is effective, easy to 













Physiologically, CPAP causes airway splinting, alveo ar 
expansion and stabilization, improved alveolar ventila-
tion and enhanced oxygenation 6. The clinical conse-
quences of these are; disappearance of grunting sound  a 
drop in the respiratory rate and an improvement in 
SPO2. 
The objective of this communication is to provide evi-
dence in support of the immediate clinical effectiveness 
of the NHA-BCPAP device. The findings would provide 
justification for a planned comparative evaluation of this 
device with other conventional commercial CPAP de-
vices. It was hypothesized that application of the NHA 
bubble CPAP device to a baby with respiratory distress 
would result in an immediate functional improvement in 




Subjects and methods 
 
This was a prospective observational study in which 
babies admitted into the newborn unit of the National 
Hospital Abuja with respiratory distress were eligible if 
they had no congenital abnormalities (bilateral choanal 
atresia, congenital diaphragmatic hernia and cleft lip/
palate). These babies would otherwise have received 
supplemental intranasal oxygen in addition to other 
management relevant to their primary pathologic diag-
nosis. There are no facilities for mechanical ventilation 
and only a limited number of variable-flow nasal CPAP 
devices are available in the unit. Babies were recruited 
into the study following parental informed consent a d 
Hospital ethics committee approval.  
 
A circuit of tubing attached to a gas source (oxygen cyl-
inder or concentrator) was connected through an inter-
face (nasal prongs) to the baby and this was further con-
nected through an expiratory limb of the tube to an  
under-water-seal bottle to generate bubble CPAP5.   The 
oxygen flow meter is connected to a humidifier contai -
ing warm distilled water and this ensures the delivery of 
warm humidified air to the baby. The high flow rate (6-
8L/Min) prevents re-breathing and carbon dioxide accu-
mulation while also ensuring adequate bubbling and 
under-water pressure generation. 
 
Forty eight babies admitted into the newborn unit with 
respiratory distress (intercostal, subcostal or stenal re-
cessions, grunting and nasal flaring) over a period of 6 
months were treated with this device. They were clini-
cally assessed on admission and at 1, 6 and 12hours af-
ter commencement of CPAP. Respiratory rates, cyano-
sis, grunting and SPO2 were documented. Also noted 
and documented were baby’s gestational age (using 
mothers’ EDD and Ballard’s score within 24 hours of 
birth), birth weight and diagnosis. The mean (SD) value 
of RR and SPO2 before CPAP was commenced was 
compared with the corresponding mean (SD) values at 
1,6 and 12 hours after commencement of CPAP and 
subjected to statistical analysis (Student t-test) to deter-
mine the significance of observed differences. Babies 
who did not improve on CPAP or died while still on 
CPAP were classified as CPAP failures. The overall 
mortality rates as well as the case specific mortality rates 






               Table 1: General characteristics  
Indicators of clinical effectiveness (tables 2-5 ) 
 
The respiratory rate dropped from a mean (SD) value of 
64.1 (18.3)/min to 59.5 (11.7)/min within 1 hour of
commencing CPAP and this downward trend was main-
tained, achieving a level of statistical significane at 6 
and 12 hours post commencement. The changes ob-
served in the SPO2 levels also followed the same pattern 
albeit more rapidly and this was synchronous with im-
provement in the level of cyanosis and the disappear-
ance of grunting sound. Further stratification of the  
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25(52.1%) 











 Respiratory Distress Syndrome 
 Congenital pneumonia 
 Cyanotic Congenital heart disease 
 Transient Tachypnoea of the Newborn 
 Recurrent Apnea 









in tables shows that respiratory rate changes are only 
significant for the LBW and NBW babies, whereas the
changes in SPO2   are uniformly significant across birth 
weight categories .      
Two extremely low birth weight babies and two with 
suspected cyanotic congenital heart disease had SPO2 
persistently below 82% throughout the period of obser-
vation. In six babies (4 VLBW, 2 ELBW), CPAP was  
reapplied after weaning, as a result of worsening respi a-
tory distress. The P values were determined by compar-
ing the mean (SD) values at 1 hr, 6 hrs and 12 hrs inde-
pendently with the mean (SD) at 0 hr.  
 
 
Table 2: Indicators of clinical effectiveness 
 
Table 3: Respiratory rates (per minute) before and after com-
mencement of B CPAP in relation to birth weight category 
NS=not significant 
Table 4: Changes in SPO2 (%) in relation gestational age  
category 
Table 5: Variable/sign number of babies with sign   
               Before CPAP  1hr after CPAP   6hrs after CPAP  12hrs after  
 
Grunting      8 (79.2%)        26(54.2%)        10(20.8%)         6(12.5%) 
Cyanosis      48 (100%)       22(45.8%)        15(3.3%)        10(20.8%)      
 
Ten babies died giving an overall mortality rate of 
20.8%.  Two of the five mortalities in the RDS group 
were ELBW, two had sepsis and 1 had recurrent apnoea.  
Two term normal birth weight babies with suspected 
Cyanotic congenital heart disease died before specific 
Echocardiographic diagnosis could be made. Mortality 
rate was 17.4% among inborn babies and 24% among 
out born babies. Gestational Age related mortality ra es 
Variable     CPAP                      Duration 





























































0 hour 1 hour         (P) 6 hour        (P) 12 hour      (P) 
ELBW 82.6(12.6) 97.0(3.0)   0.06 97.2(2.0) 0.04 97.8(1.8) 0.480 
VLBW 87.7(15.0) 97.3(2.2)   0.01 98.3(1.6) 0.01 97.8(9 7) 0.01 
LBW 80.0(16.3) 94.7(6.5)  0.01 94.6(8.3) 0.01 91.8(3.2) 0.04 
NBW 83.0(15.0) 94.2(7.7)  0.04 92.6(9.3) 0.07 95.5(4.2) 0.030 
were: ELBW (60%), VLBW (33%), LBW (44%) and 
NBW (30%). 
Table 6 shows the case specific mortality rates with
100% mortality for recurrent apnoea and severe hypoxic 
encephalopathy. 
 





Low-cost and simplified forms of the CPAP delivery 
systems have been described 7,8. The uniqueness of our 
customized device lies in its simplicity and cost effec-
tiveness. Some other modified BCPAP devices report-
edly use corrugated tubes, Hudson’s nasal prongs9 or 
shortened endotracheal tubes7 which need to be sourced 
separately, with additional cost burden.  
Respiratory Distress Syndrome in very premature neo-
nates is an important indication for nasal CPAP10,11,12. 
However, CPAP has also been successfully used in  
infants with other respiratory conditions, for instance, 
Jocelyn Brown et al13 in Malawi, demonstrated the ef-
fectiveness of CPAP  in the management of congenital 
pneumonia and as well as in an infant with Bronchioli-
tis. In our study, we recruited neonates with respiratory 
distress syndrome (30) as well as those with respiratory 
distress from other causes (18) including pneumonia   
and congenital heart disease. 
 
We set out to demonstrate that our novel device pro-
duces physiologic responses similar to those previously 
observed and documented with different forms of 
CPAP. Ongoing observations and monitoring of the 
clinical condition (respiratory rate, heart rate, grunting 
and cyanosis) and oxygen saturation of patients provide 
the best assessment of the effectiveness of CPAP14.   
Clinical evidence of an effective CPAP includes a de-
clining respiratory rate and heart rate, as well as increas-
ing oxygenation15. In our study, the changes we ob-
served; reduction in respiratory rate, increased SPO2, 
and disappearance of cyanosis as well as grunting, there-
fore point to the promising clinical effectiveness of the 
customized B-CPAP device.  Patrick Wilson et al16 in 
Ghana had demonstrated a significant drop in respiratory 
rate among young children aged three months to two 
years with Pneumonia treated with CPAP early in the 
course of their illness. The outcome in these babies from 
their study was significantly better than those in whom 
there was a delay (1 hour) in commencing CPAP.  The 
usefulness of pulse oximetry as a monitoring tool for 
babies on CPAP was noted by Malik et al17 who re-
ported a rapid rise in SPO2 to >85% and this was sus-
tained among survivors. This pattern of response is imi-
lar to the findings in our study.  
Diagnosis Mortality Rate 
Respiratory Distress Syndrome 5(16.7%) 
Congenital pneumonia 1(9.1%) 
Cyanotic Congenital heart disease 2 (66.7%) 
Transient Tachypnoea of the Newborn 0(0%) 
Recurrent Apnea 1(100%) 
Hypoxic Ischaemic Encephalopathy 1(100%) 
14 
The improvement in SPO2 values (oxygenation) was 
quite rapid and this preceded the significant reduction in 
respiratory rate. This is similar to the findings of Wag-
staff et al18 who reported an immediate improvement in 
oxygenation when they changed from open-mask to a 
closed CPAP system in a lung model simulating acute 
respiratory failure. The difference in respiratory changes 
in the birth weight categories may be a reflection of  
gestational age dependent respiratory rate variability. 
 
Majority of the babies who did not respond to CPAP 
were either extreme LBW or had cyanotic congenital 
heart disease. These would have required mechanical 
ventilation and intensive haemodynamic assessment and 
support respectively. Similarly, babies with recurrent 
apnoea and severe hypoxic ischaemic encephalopathy 
responded poorly to CPAP (as shown in table 4) pre-
sumably because they were unable to centrally maintain 
adequate respiratory drive needed to benefit from CPAP 
application.  Documented causes of CPAP failure  
include extreme low birth weight, recurrent apnoea, neo-
natal sepsis/pneumonia9,18,19 intracranial haemorrhage 
and non administration of antenatal steroid20 In the ab-
sence of facilities for arterial blood gases, as is the case 
in several hospitals in Nigeria, clinical assessment and 
bedside pulse oximetry are recommended for monitorig 
babies on CPAP.    
 
The limitation to this study is that our device does not 
provide blended oxygen, making it difficult to regulate 
the FiO2. However, intermittent passage of air through 
the mouth and nostrils into the nasopharyngeal space 
cannot be completely ruled out, thus allowing for sme 
air-oxygen blending in the nasopharynx. Furthermore, 
most oxygen concentrators deliver 80-85% O2. These 
tend to provide some window of safety against oxygen 
toxicity. The mean values of SPO2 over the period of 
observation was < 97%, therefore the risk of hyperoxae-
mia and the resultant effect on the retina especially in 
the ELBW/VLBW babies was expectedly minimized. 
Although the level of oxygen saturation associated with 
severe retinopathy of prematurity is not clearly defined, 
a Meta analysis by Minghua et al21 on the association 
between severe ROP in preterms and SPO2 levels 
showed that SPO2 values between 70%-96% in the early 
postnatal weeks was associated with reduced risk of 
severe ROP. Long term ophthalmologic follow up of 
these babies is however required for early detection of 






The NHA-BCPAP device produces immediate clinical 
responses similar to those reported for the conventional 
CPAP devices. It is therefore a viable alternative o the 
more expensive commercial CPAP devices and is there-
fore recommended for use in tertiary and secondary 
health centers in low-resource setting. Extended obser-
vations will however be needed to establish its long term 
benefits.  
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